Clinical Trials Browser

INDUSTRY × Neoplasms, Plasma Cell × Darbepoetin alfa × Clear all

NCT00095277 2009-03-13

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

Phase 2 Completed

Classical hematologyPlasma cell

Anemia, Neoplasms, Plasma Cell